Screener
Standard BioTools Inc. LAB Q3 2025 earnings
Reported November 4, 2025 · After market close
Revenue$19.6MBeat by $1.1M
EPS-$0.04Miss by $0.02
Revenue estimate$18.5M
EPS estimate-$0.03
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$18.8M
EPS estimate-$0.02
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Standard BioTools Inc. report Q3 2025 earnings?
- Standard BioTools Inc. (LAB) reported Q3 2025 earnings on November 4, 2025 after market close.
- What were Standard BioTools Inc.'s Q3 2025 revenue and EPS?
- Standard BioTools Inc. reported revenue of $19.6M and eps of $-0.04 for Q3 2025.
- Did Standard BioTools Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $18.5M by $1.1M. EPS missed the consensus estimate of $-0.03 by $0.01.
- How did Standard BioTools Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 56.5% from $45.0M a year earlier and eps grew 20.0% from $-0.05.
- Where can I find Standard BioTools Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-264693) and the 10-Q periodic report (0001193125-25-264695) directly on SEC EDGAR. The filing index links above go to sec.gov.
